Clinical observation of the short-term efficacy of the treatment with combination of all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in newly diagnosed acute promyelocytic leukemia (APL)

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Volumn 24, Issue 1, 2003, Pages 25-27

  Liu, Yuan fang ^a   Shen, Zhi xiang ^a   Chen, Xiao ^a   Wang, Ai hua ^a   Cao, Q ^a   Zhu, Yong mei ^a   Chen, Sai juan ^a   Chen, Zhu ^a   Wang, Zhen yi ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; ONCOPROTEIN; ORGANOARSENIC DERIVATIVE; OXIDE; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; RETINOIC ACID;

ADOLESCENT; ADULT; ARTICLE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETICS; HUMAN; MALE; MIDDLE AGED; PROMYELOCYTIC LEUKEMIA; REMISSION; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARSENICALS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; OXIDES; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME; TRETINOIN;

EID: 34447651099     PISSN: 02532727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)